An open label, single dose, two period, single sequence crossover study to assess the pharmacokinetic interaction of QAB149 [indacaterol] (300 mcg via inhalation) with ketoconazole (200 mg tablet b.i.d.) in healthy adult subjects

Trial Profile

An open label, single dose, two period, single sequence crossover study to assess the pharmacokinetic interaction of QAB149 [indacaterol] (300 mcg via inhalation) with ketoconazole (200 mg tablet b.i.d.) in healthy adult subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Jun 2007

At a glance

  • Drugs Indacaterol (Primary) ; Ketoconazole
  • Indications Asthma; Chronic obstructive pulmonary disease; Mycoses
  • Focus Pharmacokinetics
  • Sponsors Novartis
  • Most Recent Events

    • 18 Jun 2007 Status change from initiated to completed
    • 02 Jan 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top